IMMNOV Immunovia AB (publ)

0.0711SEK-6.45%Mkt Cap: 4.57M $P/E: —

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins a…

Key Statistics

Company
Market Cap4.57M USD
Enterprise Value1.86M USD
Revenue (TTM)115.83K USD
Gross Profit52.51K USD
Net Income (TTM)-13.96M USD
Revenue/Share0.0020 SEK
Last Price0.0711 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees18
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0006091997
Valuation
P/E (Trailing)—
P/E (Forward)0.01
PEG—
EV/EBITDA-0.23
EV/Revenue16.10
P/S42.22
P/B2.17
EPS (TTM)-0.14
EPS (Forward)7.00
52W Range
0.06601% of range0.4700
52W High0.4700 SEK
52W Low0.0660 SEK
Profitability
Gross Margin80.15%
Oper. Margin-6011.29%
EBITDA Margin0.00%
Profit Margin-21301.46%
ROE-225.30%
ROA-165.41%
Growth
Revenue Growth323.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.50M USD
CapEx (TTM)531.73K USD
FCF Margin-3327.10%
FCF Yield-84.24%
Net Debt-3.03M USD
Net Debt/EBITDA0.38
Balance Sheet
Debt/Equity0.01
Current Ratio1.57
Quick Ratio1.55
Book Value/Sh0.04 SEK
Cash/Share0.05 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.4300 SEK
Upside (mean)+504.8%
Target Range0.4300 SEK – 0.4300 SEK
# Analysts1
Ownership
Shares Out.672.67M
Float619.73M
Insiders9.77%
Institutions16.13%
Technical
SMA 500.1494 (-52.4%)
SMA 2000.1835 (-61.3%)
Beta2.64
S&P 52W Chg14.58%
Avg Vol (30d)4.99M
Avg Vol (10d)6.67M
Technical Indicators
RSI (14)19.7
MACD-0.0186
MACD Signal-0.0115
MACD Hist.-0.0071
BB Upper0.1868 SEK
BB Middle0.1301 SEK
BB Lower0.0735 SEK
BB Width87.02%
ATR (14)0.0151 SEK
Vol Ratio (20d)1.38x